TY - BOOK PY - 2006 DA - 2006// TI - Council Conclusions on Common values and principles in European Union Health Systems ID - ref1 ER - TY - CHAP PY - 2008 DA - 2008// BT - Safe, Innovative and Accessible Medicines: a Renewed Vision for the Pharmaceutical Sector ID - ref2 ER - TY - CHAP AU - Fabrizia, B. I. G. N. A. M. I. AU - P, E. PY - 2007 DA - 2007// BT - EURORDIS SURVEY ON ORPHAN DRUGS: AVAILABILITY IN EUROPE ID - Fabrizia2007 ER - TY - STD TI - 5th EURORDIS Survey On Access To Orphan Drugs In Europe Survey. [http://img.eurordis.org/newsletter/pdf/mar-2011/ERTC_13122010_YLeCam_Final.pdf] UR - http://img.eurordis.org/newsletter/pdf/mar-2011/ERTC_13122010_YLeCam_Final.pdf ID - ref4 ER - TY - CHAP PY - 2010 DA - 2010// BT - Background report for the ministerial conference ‘Innovation and solidarity on pharmaceuticals’. A call to make valuable innovative medicines available in the European Union ID - ref5 ER - TY - STD TI - EU Council Conclusions on Innovation and Solidarity in Pharmaceuticals. 2010, [http://www.consilium.europa.eu/uedocs/cms_Data/docs/pressdata/en/lsa/118278.pdf] UR - http://www.consilium.europa.eu/uedocs/cms_Data/docs/pressdata/en/lsa/118278.pdf ID - ref6 ER - TY - STD TI - Process on Corporate Responsibility in the field of Pharmaceuticals. [http://ec.europa.eu/enterprise/sectors/healthcare/competitiveness/process_on_corporate_responsibility/index_en.htm] UR - http://ec.europa.eu/enterprise/sectors/healthcare/competitiveness/process_on_corporate_responsibility/index_en.htm ID - ref7 ER - TY - CHAP AU - Picavet, E. PY - 2012 DA - 2012// TI - Market uptake of orphan drugs - a European analysis BT - J Clin Pharm Ther ID - Picavet2012 ER - TY - STD TI - Eminet: [http://www.goeg.at/en/Area/Pharma-economics.html] UR - http://www.goeg.at/en/Area/Pharma-economics.html ID - ref9 ER - TY - STD TI - EUCERD (European Union Committee of Experts on Rare Diseases): [http://www.eucerd.eu/] UR - http://www.eucerd.eu/ ID - ref10 ER -